These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17054241)

  • 41. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial.
    O'Grady JG; Burroughs A; Hardy P; Elbourne D; Truesdale A;
    Lancet; 2002 Oct; 360(9340):1119-25. PubMed ID: 12387959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tacrolimus in transplant rejection.
    Rath T
    Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Wong SC; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.
    Mazariegos GV; Salzedas AA; Jain A; Reyes J
    Paediatr Drugs; 2001; 3(9):661-72. PubMed ID: 11688597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
    Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
    Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis - a propensity score-matched intention-to-treat analysis.
    Åberg F; Sallinen V; Tuominen S; Adam R; Karam V; Mirza D; Heneghan MA; Line PD; Bennet W; Ericzon BG; Grat M; Lodge P; Rasmussen A; Schmelzle M; Thorburn D; Fondevila C; Helanterä I; Nordin A;
    J Hepatol; 2024 Jan; 80(1):99-108. PubMed ID: 37722533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of tacrolimus and cyclosporine for immunosuppression after renal transplantation: An updated systematic review and meta-analysis.
    Azarfar A; Ravanshad Y; Mehrad-Majd H; Esmaeeli M; Aval SB; Emadzadeh M; Salehi M; Moradi A; Golsorkhi M; Khazaei MR
    Saudi J Kidney Dis Transpl; 2018; 29(6):1376-1385. PubMed ID: 30588970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
    Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients.
    Goring SM; Levy AR; Ghement I; Kalsekar A; Eyawo O; L'Italien GJ; Kasiske B
    Curr Med Res Opin; 2014 Aug; 30(8):1473-87. PubMed ID: 24628478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis.
    Oliveras L; Coloma A; Lloberas N; Lino L; Favà A; Manonelles A; Codina S; Couceiro C; Melilli E; Sharif A; Hecking M; Guthoff M; Cruzado JM; Pascual J; Montero N
    Transplant Rev (Orlando); 2024 Jul; 38(3):100856. PubMed ID: 38723582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
    Watt KD; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tacrolimus Versus Cyclosporine as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation.
    Liu JY; You RX; Guo M; Zeng L; Zhou P; Zhu L; Xu G; Li J; Liu D
    Am J Ther; 2016; 23(3):e810-24. PubMed ID: 25299636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High tacrolimus intra-patient variability is associated with graft rejection, and
    Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
    World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.
    Wiesner RH
    Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
    Mühlbacher F;
    Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
    [No Abstract]   [Full Text] [Related]  

  • 58. A Comparison Between Tacrolimus and Cyclosporine As Immunosuppression after Renal Transplantation in Children, A Meta-Analysis and Systematic Review.
    Ravanshad Y; Azarfar A; Ravanshad S; Naderi Nasab M; Ghasemi A; Golsorkhi M; Mostafavian Z; Esmaeeli M; Mehrad Majd H
    Iran J Kidney Dis; 2020 Mar; 14(2):145-152. PubMed ID: 32165600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
    Orme ME; Jurewicz WA; Kumar N; McKechnie TL
    Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
    Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.